![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/32 | (2006.01) |
A61K 45/06 | (2013.01) | ||
A61K 39/00 | (2006.01) | ||
A61K 31/138 | (2013.01) | ||
A61K 31/496 | (2006.01) | ||
A61K 31/4196 | (2013.01) | ||
A61K 31/519 | (2006.01) | ||
A61K 31/565 | (2013.01) | ||
A61K 31/565 | (2006.01) | ||
C07K 16/32 | (2013.01) | ||
A61K2039/505 | (2013.01) | ||
C07K2317/31 | (2013.01) | ||
C07K2317/76 | (2013.01) | ||
A61K 39/001106 | (2018.08) | ||
A61P 35/00 | (2018.01) |
(11) | Number of the document | 3625264 |
(13) | Kind of document | T |
(96) | European patent application number | 18733959.3 |
Date of filing the European patent application | 2018-05-17 | |
(97) | Date of publication of the European application | 2020-03-25 |
(45) | Date of publication and mention of the grant of the patent | 2023-06-28 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/NL2018/050329 |
Date | 2018-05-17 |
(87) | Number | WO 2018/212656 |
Date | 2018-11-22 |
(30) | Number | Date | Country code |
201762507675 P | 2017-05-17 | US |
(72) |
MAUSSANG-DETAILLE, David Andre Baptiste , NL
GEUIJEN, Cecilia Anna Wilhelmina , NL
|
(73) |
Merus N.V. ,
Uppsalalaan 17
3e en 4e verdieping, 3584 CT Utrecht,
NL
|
(54) | COMBINATION OF AN ERBB-2/ERBB-3 BISPECIFIC ANTIBODY WITH ENDOCRINE THERAPY FOR BREAST CANCER |
COMBINATION OF AN ERBB-2/ERBB-3 BISPECIFIC ANTIBODY WITH ENDOCRINE THERAPY FOR BREAST CANCER |